Liver CancerPhase 2NCT07223307
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
13 Phase 2 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Liver and bile duct13 studies
Liver CancerPhase 2NCT07223307
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
Hepatocellular CarcinomaPhase 2NCT04472767
Nivolumab, Ipilimumab, Cabozantinib, Transarterial Chemoembolization
Intrahepatic CholangiocarcinomaPhase 2NCT04891289Papers
Gemcitabine, Oxaliplatin, Dexamethasone, Floxuridine (FUDR)
Hepatocellular CarcinomaPhase 2NCT06789757Papers
Memantine Hydrochloride, Bevacizumab, Atezolizumab
Intrahepatic CholangiocarcinomaPhase 2NCT07766187
Histotripsy, Durvalumab, Biopsy
CholangiocarcinomaPhase 2NCT05967182
Pembrolizumab, Gemcitabine, Cisplatin
Intrahepatic CholangiocarcinomaPhase 2NCT06728410
Pemigatinib, Durvalumab
HCC - Hepatocellular CarcinomaPhase 2NCT07586046Papers
Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres
Locally Advanced Ampulla of Vater CarcinomaPhase 2NCT07780838
Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab
Hepatocellular CarcinomaPhase 2NCT06526338
1.0% IP-001 for injection, Surgical Resection and Local Ablation, Local Ablation Alone
Hepatocellular Carcinoma (HCC)Phase 2NCT07689175
Nivolumab, Ipilimumab (3 mg/kg)
Locally Advanced Hepatocellular CarcinomaPhase 2NCT05168163
Atezolizumab, Cabozantinib, Lenvatinib
Hepatocellular CarcinomaPhase 2NCT05669339
Irinotecan, Sonidegib, Sorafenib